San Francisco, CA, United States of America

Kee Wong

This inventor holds 3 USPTO granted patents. Top assignee: Cytokinetics, Inc.. Active years: 2002-2004.


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2002-2004

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Kee Wong: Innovator in Biotech

Introduction

Kee Wong is a prominent inventor based in San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in the study of Aspergillus fumigatus. With a total of 3 patents to his name, Wong's work focuses on the development of methods and kits for screening modulators of important proteins.

Latest Patents

Wong's latest patents include innovations related to Aspergillus fumigatus profilin and cofilin. The Aspergillus fumigatus profilin patent provides isolated nucleic acid and amino acid sequences of profilin, along with methods and kits for screening for profilin modulators. Similarly, the Aspergillus fumigatus cofilin patent offers isolated nucleic acid and amino acid sequences of cofilin, as well as methods and kits for screening for cofilin modulators.

Career Highlights

Kee Wong is currently employed at Cytokinetics, Inc., where he continues to advance his research in biotechnology. His work has been instrumental in understanding the mechanisms of action of various proteins, which can lead to new therapeutic approaches.

Collaborations

Wong collaborates with several professionals in his field, including his coworker Corey E Nislow. Their combined expertise enhances the research efforts at Cytokinetics, Inc.

Conclusion

Kee Wong is a dedicated inventor whose work in biotechnology has the potential to impact medical research significantly. His innovative patents reflect his commitment to advancing the understanding of critical biological processes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…